Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Apr;76(4):352–355. doi: 10.1136/adc.76.4.352

One week treatment for Helicobacter pylori infection

D Walsh 1, N Goggin 1, M Rowland 1, M Durnin 1, S Moriarty 1, B Drumm 1
PMCID: PMC1717144  PMID: 9166031

Abstract

Accepted 8 November 1996


Helicobacter pylori is associated with primary antral gastritis, duodenal ulceration, and gastric cancer. Current regimens for treating infection in children using bismuth and antibiotics for two to six weeks are cumbersome. The aim of this study was to evaluate a one week course of treatment. All children undergoing endoscopy were assessed for the presence of H pylori by culture, histology, rapid urease test, and 13C urea breath test. Infected children received a one week course of colloidal bismuth subcitrate 480 mg/1.73 m2/day (maximum 120 mg four times a day), combined with metronidazole 20 mg/kg/day (maximum 200 mg three times a day), and clarithromycin 15 mg/kg/day (maximum 250 mg twice a day). To optimise compliance, drugs were dispensed in a `Redidose' box containing a compartment for each day, and subcompartments marked `breakfast', `lunch', `dinner', and `bedtime'. Compliance and side effects were assessed immediately after treatment. A urea breath test was performed at least one month after treatment. Twenty two children infected with H pylori were entered into the study; 20 of these took all doses; two children suffered significant side effects (diarrhoea and vomiting). H pylori was eradicated in 21 of the 22 children (95.45%; 95% confidence interval 77% to 100%). This study shows that H pylori infection in children can be cleared by a one week course of treatment.



Full Text

The Full Text of this article is available as a PDF (97.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banatvala N., Davies G. R., Abdi Y., Clements L., Rampton D. S., Hardie J. M., Feldman R. A. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut. 1994 Nov;35(11):1562–1566. doi: 10.1136/gut.35.11.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell G. D., Powell K. U., Burridge S. M., Bowden A. F., Atoyebi W., Bolton G. H., Jones P. H., Brown C. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Feb;9(1):41–46. doi: 10.1111/j.1365-2036.1995.tb00349.x. [DOI] [PubMed] [Google Scholar]
  3. Blaser M. J., Chyou P. H., Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995 Feb 1;55(3):562–565. [PubMed] [Google Scholar]
  4. Blaser M. J. Epidemiology and pathophysiology of Campylobacter pylori infections. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 1):S99–106. doi: 10.1093/clinids/12.supplement_1.s99. [DOI] [PubMed] [Google Scholar]
  5. Chen T. S., Tsay S. H., Chang F. Y., Lee S. D. Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: comparison of 1 week and 2 week regimens and recrudescence rates over 12 months. J Gastroenterol Hepatol. 1995 May-Jun;10(3):300–305. doi: 10.1111/j.1440-1746.1995.tb01097.x. [DOI] [PubMed] [Google Scholar]
  6. Clyne M., Drumm B. Adherence of Helicobacter pylori to primary human gastrointestinal cells. Infect Immun. 1993 Oct;61(10):4051–4057. doi: 10.1128/iai.61.10.4051-4057.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coghlan J. G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., Keane C., O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet. 1987 Nov 14;2(8568):1109–1111. doi: 10.1016/s0140-6736(87)91545-5. [DOI] [PubMed] [Google Scholar]
  8. Drumm B. Helicobacter pylori in the pediatric patient. Gastroenterol Clin North Am. 1993 Mar;22(1):169–182. [PubMed] [Google Scholar]
  9. Drumm B. Helicobacter pylori. Arch Dis Child. 1990 Nov;65(11):1278–1282. doi: 10.1136/adc.65.11.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Drumm B., Sherman P., Chiasson D., Karmali M., Cutz E. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin. J Pediatr. 1988 Nov;113(5):908–912. doi: 10.1016/s0022-3476(88)80030-1. [DOI] [PubMed] [Google Scholar]
  11. Drumm B., Sherman P., Cutz E., Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med. 1987 Jun 18;316(25):1557–1561. doi: 10.1056/NEJM198706183162501. [DOI] [PubMed] [Google Scholar]
  12. Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991 Jun 1;302(6788):1302–1305. doi: 10.1136/bmj.302.6788.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gormally S. M., Prakash N., Durnin M. T., Daly L. E., Clyne M., Kierce B. M., Drumm B. Association of symptoms with Helicobacter pylori infection in children. J Pediatr. 1995 May;126(5 Pt 1):753–756. doi: 10.1016/s0022-3476(95)70405-1. [DOI] [PubMed] [Google Scholar]
  14. Graham D. Y., Adam E., Reddy G. T., Agarwal J. P., Agarwal R., Evans D. J., Jr, Malaty H. M., Evans D. G. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991 Aug;36(8):1084–1088. doi: 10.1007/BF01297451. [DOI] [PubMed] [Google Scholar]
  15. Hassall E., Dimmick J. E. Unique features of Helicobacter pylori disease in children. Dig Dis Sci. 1991 Apr;36(4):417–423. doi: 10.1007/BF01298868. [DOI] [PubMed] [Google Scholar]
  16. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  17. Humphreys H., Bourke S., Dooley C., McKenna D., Power B., Keane C. T., Sweeney E. C., O'Moráin C. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. Gut. 1988 Mar;29(3):279–283. doi: 10.1136/gut.29.3.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Israel D. M., Hassall E. Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children. J Pediatr. 1993 Jul;123(1):53–58. doi: 10.1016/s0022-3476(05)81536-7. [DOI] [PubMed] [Google Scholar]
  19. Kilbridge P. M., Dahms B. B., Czinn S. J. Campylobacter pylori--associated gastritis and peptic ulcer disease in children. Am J Dis Child. 1988 Nov;142(11):1149–1152. doi: 10.1001/archpedi.1988.02150110027012. [DOI] [PubMed] [Google Scholar]
  20. Marshall B. J., Goodwin C. S., Warren J. R., Murray R., Blincow E. D., Blackbourn S. J., Phillips M., Waters T. E., Sanderson C. R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24;2(8626-8627):1437–1442. doi: 10.1016/s0140-6736(88)90929-4. [DOI] [PubMed] [Google Scholar]
  21. Matysiak-Budnik T., Briet F., Heyman M., Mégraud F. Laboratory-acquired Helicobacter pylori infection. Lancet. 1995 Dec 2;346(8988):1489–1490. doi: 10.1016/s0140-6736(95)92506-6. [DOI] [PubMed] [Google Scholar]
  22. Nomura A., Stemmermann G. N., Chyou P. H., Kato I., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991 Oct 17;325(16):1132–1136. doi: 10.1056/NEJM199110173251604. [DOI] [PubMed] [Google Scholar]
  23. Ozmen M. M., Johnson C. D. Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? Am J Gastroenterol. 1995 Sep;90(9):1542–1543. [PubMed] [Google Scholar]
  24. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  25. Peterson W. L. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991 Apr 11;324(15):1043–1048. doi: 10.1056/NEJM199104113241507. [DOI] [PubMed] [Google Scholar]
  26. Queiroz D. M., Moura S. B., Mendes E. N., Rocha G. A., Barbosa A. J., de Carvalho A. S. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children. Lancet. 1994 May 14;343(8907):1191–1193. doi: 10.1016/s0140-6736(94)92401-5. [DOI] [PubMed] [Google Scholar]
  27. Reifen R., Rasooly I., Drumm B., Murphy K., Sherman P. Helicobacter pylori infection in children. Is there specific symptomatology? Dig Dis Sci. 1994 Jul;39(7):1488–1492. doi: 10.1007/BF02088053. [DOI] [PubMed] [Google Scholar]
  28. Yeung C. K., Fu K. H., Yuen K. Y., Ng W. F., Tsang T. M., Branicki F. J., Saing H. Helicobacter pylori and associated duodenal ulcer. Arch Dis Child. 1990 Nov;65(11):1212–1216. doi: 10.1136/adc.65.11.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. de Boer W., Driessen W., Jansz A., Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995 Apr 1;345(8953):817–820. doi: 10.1016/s0140-6736(95)92962-2. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES